CFI-400945 is not a selective cellular PLK4 inhibitor
Author:
Funder
Ludwig Institute for Cancer Research
HHS | NIH | National Institute of General Medical Sciences
Publisher
Proceedings of the National Academy of Sciences
Subject
Multidisciplinary
Reference10 articles.
1. Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
2. Polo-like kinases: structural variations lead to multiple functions
3. Reversible centriole depletion with an inhibitor of Polo-like kinase 4
4. Actin- and microtubule-dependent regulation of Golgi morphology by FHDC1
5. Mitotic Golgi disassembly is required for bipolar spindle formation and mitotic progression
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-07-15
2. PLK4, a potential target against AML;Blood;2023-12-07
3. Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML;Blood;2023-12-07
4. Targeting mitotic regulators in cancer as a strategy to enhance immune recognition;DNA Repair;2023-12
5. Discovery of the First Potent, Selective, and In Vivo Efficacious Polo-like Kinase 4 Proteolysis Targeting Chimera Degrader for the Treatment of TRIM37-Amplified Breast Cancer;Journal of Medicinal Chemistry;2023-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3